共 39 条
[11]
OCCURRENCE OF SERIOUS BACTERIAL INFECTIONS SINCE INTRODUCTION OF ANTIBACTERIAL AGENTS
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1959, 170 (18)
:2188-2197
[12]
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1994, 271 (23)
:1836-1843
[13]
FISHER CJ, 1994, JAMA-J AM MED ASSOC, V272, P1170
[14]
IMPAIRMENT AFTER ADULT RESPIRATORY-DISTRESS SYNDROME - AN EVALUATION BASED ON AMERICAN THORACIC SOCIETY RECOMMENDATIONS
[J].
AMERICAN REVIEW OF RESPIRATORY DISEASE,
1989, 139 (05)
:1158-1162
[15]
GREEN J, 1995, J AM SOC NEPHROL, V5, P1853
[16]
A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1991, 266 (08)
:1097-1102
[19]
THE CLINICAL-EVALUATION OF NEW DRUGS FOR SEPSIS - A PROSPECTIVE-STUDY DESIGN BASED ON SURVIVAL ANALYSIS
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1993, 270 (10)
:1233-1241